HSPB6 and prostate carcinoma: CCK8 results demonstrated that the combination of quinidine and 8-Br-cGMP in vitro more effectively inhibited the growth of prostate cancer cells, and knocking down HSPB6 could reverse this effect (Fig. 8A, B).